Previous 10 | Next 10 |
BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® , today annou...
BRYAN, Texas, Dec. 22, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® ,...
Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and medical personnel...
BRYAN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® , provides th...
- Shareholders Presently Supporting Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - BRYAN, Texas, Dec. 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmac...
3 Biotech Penny Stocks to Add to Your December 2021 Watchlist Investing in penny stocks and blue chips has never been more action-packed. With inflation, the Omicron variant, and other factors to consider, investors are inundated with movement that can be capitalized upon. Right now, th...
- iBio’s Board Urges Shareholders to Vote Today to Support Company’s Strategic Growth Plans - BRYAN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmace...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips News of the omicron variant of Covid-19 has sent vaccine makers into a frenzy, as companies race to make further adaptations. Many of the leading vaccine makers have already begun testing and developing new products. But ...
3 Biotech Penny Stocks to Watch With the New Variant in Mind With another interesting day of trading penny stocks and blue chips off to a good start, it’s clear that volatility is here to stay. Although it may have seemed like things were calming down in the past few weeks, the e...
- Global Reliance on Spike Protein-Based Vaccines May Create Public Health Risks - - Omicron’s Many Mutations Occur in Regions Outside Those of IBIO-202’s Nucleocapsid Antigen - - Company Expecting Feedback from U.S. FDA on IBIO-202 in January - BRYAN...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...